Reproduction/Androgen Disorders News

Testosterone therapy plus lifestyle intervention was tied to a larger improvement in sexual desire than lifestyle intervention alone among older men with impaired glucose tolerance, according to a secondary analysis of the T4DM trial.

Among menopausal women, hormone therapy use and duration were not associated with brain malignancy risk, although researchers cautioned that more research is needed, according to findings published in Menopause.

The FDA has recommended several labeling changes to all approved testosterone replacement therapy products based on the agency’s review of several studies, according to a release.

Trauma from childhood and adulthood were associated with worse measured uninterrupted sleep and worse self-reported sleep quality for midlife women, researchers reported in Menopause.

In this Healio Video Exclusive, Caroline T. Nguyen, MD, speaks with Sarit Polsky, MD, MPH, about the use of continuous glucose monitoring for pregnant women with gestational diabetes and type 1 diabetes.

In this Healio Video Exclusive, Nicole Gomez, MD, speaks with Caroline T. Nguyen, MD, about managing Graves’ disease during pregnancy.

In this Healio Video Exclusive, Caroline T. Nguyen, MD, speaks with Donna Shoupe, MD, about the health benefits of menopausal hormone therapy for women.

Recently postmenopausal women with elevated blood pressure but no other CVD risk factors were more likely to develop white matter lesions 14 years later, regardless of short-term hormone therapy use, data show.

Postmenopausal women with vulvovaginal atrophy treated with intravaginal prasterone for at least 12 weeks were nearly 50% less likely to develop a urinary tract infection compared with untreated women, researchers reported in Menopause.